aTyr Pharma to Present at Upcoming Investor Conferences
aTyr Pharma, Inc. (ATYR)
Company Research
Source: GlobeNewswire
SAN DIEGO, Oct. 31, 2024 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform, today announced that the company will present at several upcoming investor conferences scheduled to take place in November and December 2024. Details of the conferences appear below: Conference: Stifel Healthcare ConferenceDate: Monday, November 18, 2024 Time: 3:35pm ESTLocation: New York, NYFormat: Corporate Presentation Conference: Jefferies London Healthcare Conference Date: Wednesday, November 20, 2024Time: 3:00pm GMTLocation: London, UKFormat: Corporate Presentation Conference: 7th Annual Evercore HealthCONx ConferenceDate: Tuesday, December 3, 2024Time: 8:20am ESTLocation: Coral Gables, FLFormat: Fireside Chat Conference: Piper Sandler 36th Annual Healthcare ConferenceDate: Thursday, December 5, 2024Time: 12:00pm ESTLocation: New Yo
Show less
Read more
Impact Snapshot
Event Time:
ATYR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ATYR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ATYR alerts
High impacting aTyr Pharma, Inc. news events
Weekly update
A roundup of the hottest topics
ATYR
News
- aTyr Pharma Announces Third Quarter 2024 Results and Provides Corporate UpdateGlobeNewswire
- Nearly 350 Patients Participate in the Foundation for Sarcoidosis Research Externally Led Patient-Focused Drug Development Meeting with the FDA [Yahoo! Finance]Yahoo! Finance
- Atyr PHARMA INC (NASDAQ: ATYR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $35.00 price target on the stock.MarketBeat
- aTyr Pharma’s Lead Therapeutic Candidate Efzofitimod for Pulmonary Sarcoidosis to be Featured in Best of CHEST Journals at CHEST 2024 Annual MeetingGlobeNewswire
- Atyr PHARMA INC (NASDAQ: ATYR) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $17.00 price target on the stock.MarketBeat